These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32837030)

  • 21. On Setting Expectations for a Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine.
    Canaday DH; Gravenstein S
    Clin Infect Dis; 2021 Feb; 72(3):513-514. PubMed ID: 33527123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An updated review on potential therapeutic drug candidates, vaccines and an insight on patents filed for COVID-19.
    Rao GSNK; Gowthami B; Naveen NR; Samudrala PK
    Curr Res Pharmacol Drug Discov; 2021; 2():100063. PubMed ID: 34870158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coronavirus disease 2019 vaccine: An overview of the progression and current use.
    Gocer S; Turk C; Ozguven SV; Doganay M
    North Clin Istanb; 2021; 8(5):529-536. PubMed ID: 34909595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ongoing Clinical Trials of Vaccines to Fight against COVID-19 Pandemic.
    Chakraborty C; Sharma AR; Bhattacharya M; Sharma G; Saha RP; Lee SS
    Immune Netw; 2021 Feb; 21(1):e5. PubMed ID: 33728098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccines and Drug Therapeutics to Lock Down Novel Coronavirus Disease 2019 (COVID-19): A Systematic Review of Clinical Trials.
    Bhagavathula AS; Aldhaleei WA; Rovetta A; Rahmani J
    Cureus; 2020 May; 12(5):e8342. PubMed ID: 32494546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repurposing of the childhood vaccines: could we train the immune system against the SARS-CoV-2.
    Sharma D
    Expert Rev Vaccines; 2021 Sep; 20(9):1051-1057. PubMed ID: 34313516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deciphering Vaccines for COVID-19: where do we stand today?
    Baviskar T; Raut D; Bhatt LK
    Immunopharmacol Immunotoxicol; 2021 Feb; 43(1):8-21. PubMed ID: 33054486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coronavirus disease 2019 (COVID-19): latest developments in potential treatments.
    Hon KL; Leung KKY; Leung AK; Qian SY; Chan VP; Ip P; Wong IC
    Drugs Context; 2020; 9():. PubMed ID: 32655654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frontrunners in the race to develop a SARS-CoV-2 vaccine.
    Russell RL; Pelka P; Mark BL
    Can J Microbiol; 2021 Mar; 67(3):189-212. PubMed ID: 33264067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging Prevention and Treatment Strategies to Control COVID-19.
    Singh VK; Mishra A; Singh S; Kumar P; Singh M; Jagannath C; Khan A
    Pathogens; 2020 Jun; 9(6):. PubMed ID: 32585805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comprehensive overview of vaccines developed for pandemic viral pathogens over the past two decades including those in clinical trials for the current novel SARS-CoV-2.
    Damodharan K; Arumugam GS; Ganesan S; Doble M; Thennarasu S
    RSC Adv; 2021 Jun; 11(33):20006-20035. PubMed ID: 35479882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent Clinical Trials on Natural Products and Traditional Chinese Medicine Combating the COVID-19.
    Nile SH; Kai G
    Indian J Microbiol; 2021 Mar; 61(1):10-15. PubMed ID: 33390627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune Dysfunction and Multiple Treatment Modalities for the SARS-CoV-2 Pandemic: Races of Uncontrolled Running Sweat?
    Kothari A; Singh V; Nath UK; Kumar S; Rai V; Kaushal K; Omar BJ; Pandey A; Jain N
    Biology (Basel); 2020 Aug; 9(9):. PubMed ID: 32846906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19: Guidelines for pharmacists in South Africa.
    Schellack N; Coetzee M; Schellack G; Gijzelaar M; Hassim Z; Milne M; Bronkhorst E; Padayachee N; Singh N; Kolman S; Gray AL
    S Afr J Infect Dis; 2020; 35(1):206. PubMed ID: 34192121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nucleic Acid Vaccines against SARS-CoV-2.
    Liu Y; Ye Q
    Vaccines (Basel); 2022 Oct; 10(11):. PubMed ID: 36366358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methodical Design of Viral Vaccines Based on Avant-Garde Nanocarriers: A Multi-Domain Narrative Review.
    Raoufi E; Bahramimeimandi B; Salehi-Shadkami M; Chaosri P; Mozafari MR
    Biomedicines; 2021 May; 9(5):. PubMed ID: 34066608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stem cell-based therapy for COVID-19.
    Chen X; Liu B; Li C; Wang Y; Geng S; Du X; Weng J; Lai P
    Int Immunopharmacol; 2023 Nov; 124(Pt A):110890. PubMed ID: 37688914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stem Cell Based Therapy Option in COVID-19: Is It Really Promising?
    Irmak DK; Darıcı H; Karaöz E
    Aging Dis; 2020 Oct; 11(5):1174-1191. PubMed ID: 33014531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.